Amundi Glaukos Corp Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Glaukos Corp stock. As of the latest transaction made, Amundi holds 227,290 shares of GKOS stock, worth $21.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
227,290
Previous 115,418
96.93%
Holding current value
$21.5 Million
Previous $17.3 Million
29.26%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding GKOS
# of Institutions
358Shares Held
50.2MCall Options Held
260KPut Options Held
776K-
Black Rock Inc. New York, NY8.04MShares$759 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$564 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$216 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$188 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$184 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.5B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...